| 04 Avril 2013
 Results from an anonymous survey of U.S. transplant providers report  that incarceration, marijuana use, and psychiatric diagnoses,  particularly suicide attempts, may lower patients’ eligibility for liver  transplantation.  The study published in the April issue of Liver Transplantation,  a journal of the American Association for the Study of Liver Diseases  and the International Liver Transplantation Society, also found that  most providers would not offer transplants to patients with advanced  age, those severely obese, or with lifetime imprisonment.
Results from an anonymous survey of U.S. transplant providers report  that incarceration, marijuana use, and psychiatric diagnoses,  particularly suicide attempts, may lower patients’ eligibility for liver  transplantation.  The study published in the April issue of Liver Transplantation,  a journal of the American Association for the Study of Liver Diseases  and the International Liver Transplantation Society, also found that  most providers would not offer transplants to patients with advanced  age, those severely obese, or with lifetime imprisonment. 
“For patients with end-stage liver disease, transplantation is the only treatment option to extend life,” explains lead investigator Dr. Josh Levitsky from Northwestern University Feinberg School of Medicine in Chicago, Ill. “With donated livers in such short supply, selecting candidates becomes an ethical exercise for transplant specialists who must balance equal access to transplantation with graft and patient survival.”
  Currently, the model for end-stage liver disease (MELD) is used to  measure the severity of liver disease.   The MELD score provides  transplant providers with standardized criteria to allocate donated  livers.  However, the authors point out that subjective assessment of  the candidates’ medical and psychosocial characteristics could influence  the providers’ selection process.  Medical evidence shows that  controversial characteristics such as alcohol abuse, HIV status,  obesity, or advanced age may impact allocation, leading to an inequity  among patients being waitlisted.  To  further understand the ethics involved in selecting transplant  candidates, Dr. Levitsky and colleagues sent an online survey to  hepatologists, surgeons, psychiatrists and social workers at 102 liver  transplant centers across the U.S.  Responses were received from 251  providers who answered questions regarding their opinions of  characteristics that could prevent patients from receiving a liver  transplant.   The majority of responders were male (71%), between 41 and 60 years of  age (68%) and mainly white (77%).   The three characteristics ranked  most controversial were incarceration, marijuana use, and psychiatric  diagnoses.  Responses from transplant providers indicate that 63% would  not waitlist patients 80 years or older, 57% would not transplant  patients with a body mass index (BMI) greater than 45 kg/m2, and 55% specified incarceration with lifetime sentence a contraindication to liver transplantation.   Furthermore, less than half of the providers reported their centers  had written policies regarding controversial characteristics that would  prevent some patients from receiving liver transplants. “We found  significant variation in provider opinions of criteria that are  contraindications for liver transplantation, which may be why many  centers do not have formal policies for selecting candidates with  questionable characteristics,” concludes Dr. Levitsky.  “Standardized  eligibility criteria, supported by evidence-based data of outcomes, are  necessary to develop formal policies for selecting controversial  candidates for liver transplantation.”